AboutContact us
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
“Younger people are getting cancer more and more. We have to make kinder medicines.”
2
Shipping giant MSC submits bid for ZIM, challenging Hapag-Lloyd in takeover race
3
ServiceNow in advanced talks to acquire Armis at around $7 billion valuation
4
The $2.3 billion mystery arms deal Israel won’t explain
5
Armis sale to ServiceNow could yield $4 billion windfall for Insight Partners
More news

Nasdaq

20 stories about Nasdaq
מנכ"ל מדיגוס כריס רולנד

Medical Device Company Medigus Raises $10 Million in Public Offering

24.07.18|CTech
Medigus develops minimally invasive endosurgical tools and direct visualization technology
נאסד"ק וול סטריט

Gastro Treatment Company RedHill Wants to Raise $117 on Nasdaq

24.07.18|Lilach Baumer
The Tel Aviv-headquartered company announced on Monday that Nasdaq approved its listing on its second tier, the Global Market. RedHill's ADSs were previously listed on Nasdaq Capital Market
נאסד"ק וול סטריט

Nasdaq Sends Notice of Delisting to Interception Company Ability

15.07.18|CTech
Last week, Tel Aviv-based Ability announced the SEC is considering disciplinary action against it in connection to a 2015 merger, and to business information filed by the company
רון בנצור

Sustained Drug Release Company UroGen Submits New Drug Application to FDA

12.07.18|Amir Rosenbaum
Kite Pharma founder Arie Belldegrun is the chairman of Israel-based UroGen, which focuses mainly on cancer treatment and urinary tract infections
נאסד"ק וול סטריט

Oral Insulin Capsule Developer Oramed Raises $18 Million in Direct Offering

10.07.18|CTech
Jerusalem-headquartered Oramed intends to use the recent proceeds for research and development and for clinical trials
נאסדק נאסד"ק ניו יורק בורסה בועה

SEC Considering Disciplinary Action Against Interception Company Ability

09.07.18|Dror Reich
Tel Aviv-based Ability has been under probe since February 2017 in regards to a 2015 merger, and to business information filed by the company
נאסד"ק וול סטריט

Cybersecurity Company Safe-T Group Submits Preliminary Prospectus for Nasdaq IPO

08.07.18|Lilach Baumer
The company is currently listed on the Tel Aviv Stock Exchange and on the OTCQB venture market
נאסד"ק וול סטריט

Fourth Time’s the Charm for Entera Bio IPO

01.07.18|Dror Reich
The Israel-based oral drug developer listed on Nasdaq on Thursday, pricing 1.4 million units of one share and one warrant at $8 each
פרופסור קרין נהון נשיאת איגוד האינטרנט

CTech's Monday Roundup of Israeli Tech News

25.06.18|CTech
Israeli civil liberties groups warn against potential for abuse in cybersecurity bill. After hitting new low, surveillance company Ability jumps on Nasdaq
ברק עילם מנכל נייס

Nice Extends Mattersight Tender Offer for the Fourth Time

25.06.18|Dror Reich
The Israeli software company announced the acquisition agreement in April, but has been held back by the American regulator again and again
נאסד"ק וול סטריט

After Hitting New Low, Interception Company Ability Jumps on Nasdaq

25.06.18|Dror Reich
The company closed at $2.16 on Wednesday and at $4.99 on Friday, and is currently almost 10% up in pre-trading
אבישי אברהמי מ מייסדי ו מנכל חברת וויקס

Wix Looking to Raise $385 Million in Private Offering

24.06.18|Lilach Baumer
In May, Wix published its first-quarter report for 2018, reporting revenue of $137.8 million, up 49% from a year earlier
נאסד"ק וול סטריט

Liver Treatment Company Galmed Looking to Raise $75 Million in Public Offering

20.06.18|Dror Reich
Galmed listed on Nasdaq in 2014. The company's stock jumped around 125% over the past two weeks following a successful study
אייל ולדמן מלאנוקס

Mellanox and Starboard Nearing Agreement Over Board Seats, Report Says

18.06.18|Dror Reich
The two companies had been brawling over the makeup of Mellanox’s board since Starboard became the chipmaker’s largest shareholder in November
נאסדק נאסד"ק ניו יורק בורסה בועה

Biotech Company Compugen Down on Nasdaq Following $21 Million Direct Offering

17.06.18|Dror Reich
The Israel-based cancer immunotherapy company intends to use the proceedings for product development
default image

Verint Rises on Earnings, CEO Declines to Comment on NSO Deal

10.06.18|Dror Reich
In a Thursday earnings call Verint CEO Dan Bodner dodged questions about potential acquisition of NSO Group, calling it "rumors"
Strata Skin סטראטה סקין דולב רפאלי

Medtech Investment Firm Acclemed Leads $17 Million Round for Derma Company Strata

30.05.18|Meir Orbach
Following the round, Acclemed became Strata's largest shareholder
default image

Surveillance Company Verint Negotiating $1 Billion Merger with Israeli NSO Group

28.05.18|Orr Hirschauge and Amarelle Wenkert
NSO develops and sells cyber attack tools that can be used to gather intelligence from mobile phones
תרופות זירת הבריאות

Entera Bio Gives Nasdaq IPO Another Shot

21.05.18|Dror Reich
This is the fourth time since 2014 that the Jerusalem-based biomed company files for an initial public offering on Nasdaq
קורנית דיגיטל

Kornit Digital Reports Strong Sales of New Industrial Printer

10.05.18|Hezi Sternlicht
Revenue in the first quarter exceeded expectations as the maker of industrial inkjet printers for the garment industry saw high demand for its new machine
Previous ArticlesMore Articles